Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells.

Gaglia JL, Greenfield EA, Mattoo A, Sharpe AH, Freeman GJ, Kuchroo VK.

J Immunol. 2000 Dec 1;165(11):6091-8.

2.
4.

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

Hombach A, Wieczarkowiecz A, Marquardt T, Heuser C, Usai L, Pohl C, Seliger B, Abken H.

J Immunol. 2001 Dec 1;167(11):6123-31. Erratum in: J Immunol. 2004 Jul 1;173(1):695.

5.

Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.

Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K.

J Immunol. 2001 May 15;166(10):6012-8.

6.

The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Wiendl H, Neuhaus O, Mehling M, Wintterle S, Schreiner B, Mitsdoerffer M, Wienhold W, Weissert R, Wessels J, Hartung HP, Weller M, Tolosa E, Melms A.

J Neuroimmunol. 2003 Jul;140(1-2):177-87.

PMID:
12864987
7.

Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.

Damle NK, Klussman K, Leytze G, Ochs HD, Aruffo A, Linsley PS, Ledbetter JA.

Cell Immunol. 1993 Apr 15;148(1):144-56.

PMID:
7684325
8.

Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.

Evans DE, Munks MW, Purkerson JM, Parker DC.

J Immunol. 2000 Jan 15;164(2):688-97.

12.

Activated B cells express CD28/B7-independent costimulatory activity.

Ding L, Shevach EM.

J Immunol. 1996 Aug 15;157(4):1389-96.

PMID:
8759718
13.
14.

Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells.

Penninger JM, Timms E, Shahinian A, Jezo-Bremond A, Nishina H, Ionescu J, Hedrick SM, Mak TW.

J Immunol. 1995 Oct 15;155(8):3847-55.

PMID:
7561091
15.

B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.

Tan R, Teh SJ, Ledbetter JA, Linsley PS, Teh HS.

J Immunol. 1992 Nov 15;149(10):3217-24.

PMID:
1385518
16.
17.

CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.

Akiba H, Oshima H, Takeda K, Atsuta M, Nakano H, Nakajima A, Nohara C, Yagita H, Okumura K.

J Immunol. 1999 Jun 15;162(12):7058-66.

18.

Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.

Heinly CS, Sempowski GD, Lee DM, Patel DD, McDermott PM, Scearce RM, Thompson CB, Haynes BF.

Int Immunol. 2001 Feb;13(2):157-66.

PMID:
11157849
20.

MRC OX-2 defines a novel T cell costimulatory pathway.

Borriello F, Lederer J, Scott S, Sharpe AH.

J Immunol. 1997 May 15;158(10):4548-54.

PMID:
9144466

Supplemental Content

Support Center